US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 12.950
- +0.060+0.47%
Close Apr 23 16:00 ET
- 13.050
- +0.100+0.77%
Post 19:14 ET
778.38MMarket Cap-1430P/E (TTM)
13.380High12.744Low815.19KVolume12.910Open12.890Pre Close10.63MTurnover1.71%Turnover RatioLossP/E (Static)60.11MShares59.99052wk High0.97P/B615.77MFloat Cap10.92052wk Low--Dividend TTM47.55MShs Float195.970Historical High--Div YieldTTM4.93%Amplitude10.920Historical Low13.043Avg Price1Lot Size
Sage Therapeutics Stock Forum
Sign in to post a comment
ColumnsToday's Pre-Market Stock Movers And Top Ratings: UBS, DG, VSCO, PLTR and More
Pre-Market Stock Movers
Gapping up
$Salesforce(CRM.US$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group(UBS.US$ popp...
Gapping up
$Salesforce(CRM.US$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group(UBS.US$ popp...
24
1
8/8 Watchlist ⚡️
$Apellis Pharmaceuticals(APLS.US$$Alteryx(AYX.US$$Barfresh Food(BRFH.US$$Celanese Corp(CE.US$$Chegg(CHGG.US$$Chewy(CHWY.US$$Extra Space Storage Inc(EXR.US$$Five9(FIVN.US$$International Flavors & Fragrances(IFF.US$$Lucid Group(LCID.US$$Paramount Global-B(PARA.US$$Sage Therapeutics(SAGE.US$$ShockWave Medical(SWAV.US$$Teradata Corp(TDC.US$$VistaGen Therapeutics(VTGN.US$$Wynn Resorts(WYNN.US$
follow for daily watchlist 🚀
follow for daily watchlist 🚀
3
$Sage Therapeutics(SAGE.US$
Great entry point. As long as it is approved and on the market, it will be open for off-label use for MDD if someone really wants it.
Great entry point. As long as it is approved and on the market, it will be open for off-label use for MDD if someone really wants it.
1
Major is rejected. Minor is approved
$Sage Therapeutics(SAGE.US$ the medicine got approval as a quick fix for PPD 产后抑郁症 after delivery. It can make some big money for that. Sorry but women have many troubles after delivery. Well done.
However MDD 一般抑郁症 is not approved. Although they are not serious enough for MDD. MDD means huge money. And people with MDD typically take pills for years. Guess what, wall street and elites, they know mental health better than you
Now no huge money but just big mon...
However MDD 一般抑郁症 is not approved. Although they are not serious enough for MDD. MDD means huge money. And people with MDD typically take pills for years. Guess what, wall street and elites, they know mental health better than you
Now no huge money but just big mon...
2
$Sage Therapeutics(SAGE.US$ What a kick in the stones! at 4:19 PT was $70 NOW AT 5:40 it gets PT cut down to $25? kinda why i take PT with a grain of salt! GRrrrrrr!
2
5
$Sage Therapeutics(SAGE.US$ Was on FDA calendar for PDUFA action 8/5/23 after their application was granted priority review for the drug ZURANOLONE. $Biogen(BIIB.US$ was also on FDA calendar for PDUFA priority review of their application.
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
taijahmed75OP : Adding the link here: These Five Biotech Stocks Are Developing Potentially Groundbreaking Mental Health Treatments